Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJ
VanEck Pharmaceutical ETF (PPH -0.68%) provides concentrated exposure to global drugmakers, while iShares Global Healthcare ETF (IXJ -0.48%) offers broader access to the wider healthcare sector, including equipment and services companies. Investors…
Trump's tariff threat on generic drugs: Why this matters for Indian pharma companies
4 min read New Delhi Make us preferred source on Google US President Donald Trump on Tuesday (July 21) said that tariffs on generic drugs in the US will be raised 100% after two years and to 200% thereafter to “reshore” generic pharma…
Trump's 200% generic tariff threat would imperil Americans: Indian pharma
U.S. President Donald Trump has given generic pharmaceutical companies a two-year window to establish manufacturing facilities in the United States, warning that products imported after August 2028 could face tariffs of up to 200%. The…
UBS Warns Trump's 100% Generic Drug Tariff Puts Indian Pharma 'On Notice'; Goldman Flags Reshoring Winners
President Trump will impose a 100% tariff on imported generic drugs starting in August 2028, rising to 200% a year later, unless manufacturers shift production to the US. 'This is done in order to RESHORE Generic Pharmaceutical Production into…
India pharma market enters US tariff transition with strong domestic growth: Report
India's pharmaceutical market is entering the proposed two-year transition period before the United States' planned tariffs on imported generic medicines with broad-based domestic growth momentum, according to an Equirus Securities report, which…
Nuvectis Pharma (NASDAQ:NVCT) Trading 1.1% Higher - Here's What Happened
Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report)'s share price rose 1.1% during mid-day trading on Wednesday. The company traded as high as $19.75 and last traded at $19.29. Approximately 157,318 shares changed hands during mid-day trading, a…
Monashee Investment Management LLC Reduces Holdings in BridgeBio Pharma, Inc. $BBIO
Monashee Investment Management LLC reduced its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 32.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The…
Sensex, Nifty slide at open as West Asia crisis drives oil above $95; Dr Reddy's drags pharma
Benchmark indices opened lower on Thursday morning, weighed down by surging crude oil prices after Yemen's Houthi rebels attacked Saudi oil tankers, escalating the West Asia conflict and rattling investor sentiment across emerging markets. The BSE…
177,500 Shares in Royalty Pharma PLC $RPRX Acquired by Andra AP fonden
Andra AP fonden acquired a new stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 177,500 shares of the…
Trump's proposed 200% tariff is a wake-up call, India's bigger pharma risk lies in China, say experts
India reportedly supplies 47% of all generic prescriptions dispensed in the United States, making India the country's largest source of affordable generic medicines. With US President Donald Trump proposing tariffs of up to 200% on generic drug…
NewAmsterdam Pharma Company N.V. $NAMS Stake Cut by Decheng Capital LLC
Decheng Capital LLC cut its holdings in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 45.1% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission.
Bank of New York Mellon Corp Reduces Stock Position in Royalty Pharma PLC $RPRX
Bank of New York Mellon Corp decreased its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 2.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,302,043…
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Still a Buy?
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) gapped up prior to trading on Wednesday. The stock had previously closed at $18.37, but opened at $19.31. Ascentage Pharma Group International shares last traded…
Indian drugmakers rattled by Trump's 100% levy on generics
U.S. President Donald Trump's plan to impose steep tariffs on generic medicines has unsettled Indian drugmakers and put the spotlight on their strategy in their biggest export market. The NSE Nifty Pharma Index slipped 1.3% in Mumbai Wednesday…
China's tycoons rein in charitable donations, switch focus to science, education
China's tycoons have reined in their charitable donations amid weaker-than-expected economic momentum, and among those that are still giving, many are redirecting their wealth towards advancing scientific development and supporting education. The…
Receive a Daily briefing on Pharma Industry News
Get Started